Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: Optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase

Umeda, 1968, Cancer Res., 28, 2529 Heidelberger, 1964, Cancer Res., 24, 1979 Murakami, 2000, Int. J. Oncol., 17, 277 Nakayama, 1980, J. Med. Chem., 23, 962, 10.1021/jm00182a029 Rogers, 1969, Cancer Res., 29, 953 Dexter, 1972, Cancer Res., 32, 247 Ansfield, 1971, Cancer Chemother. Rep., 55, 205 el Kouni, 1993, Cancer Res., 53, 3687 Maehara, 1989, J. Surg. Oncol., 42, 184, 10.1002/jso.2930420311 Yano, S.; Kazuno, H.; Suzuki, N.; Emura, T.; Wierzba, K.; Yamashita, J.; Tada, Y.; Yamada, Y.; Fukushima, M.; Asao, T. Bioorg. Med. Chem. 2004, 12, see doi:10.1016/j.bmc.2004.04.036 Ferrario, 1991, Synth. Commun., 21, 99, 10.1080/00397919108020795 Ishikawa, 1978, Chem. Pharm. Bull., 26, 3658, 10.1248/cpb.26.3658 Miller, 1972, J. Med. Chem., 15, 415, 10.1021/jm00274a023 Lawson, 1956, J. Chem. Soc., 307, 10.1039/JR9560000307 Moriconi, 1968, J. Org. Chem., 33, 2109, 10.1021/jo01269a091 Johnson, 1913, J. Am. Chem. Soc., 35, 585, 10.1021/ja02194a012 Fukushima, 2000, Biochem. Pharmacol., 59, 1227, 10.1016/S0006-2952(00)00253-7 Furukawa, 1992, Nature, 356, 668, 10.1038/356668a0 Matsushita, 1999, Cancer Res., 59, 1911 Takao, 2000, Cancer Res., 60, 5345